The Expression of p53, p21 and TGF β1 in Gastric Carcinoma

Kurume Medical Journal

Volumn 50, Issue 42371, 2003, Pages 1-7

  Aoyagi, Keishiro ^a   Koufuji, Kikuo ^a   Yano, Shojiro ^a   Murakami, Naotaka ^a   Miyagi, Motoshi ^a   Koga, Atsuhiko ^a   Takeda, Jinryo ^a   Shirouzu, Kazuo ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

combination of p53 and p21 expression; gastric carcinoma; p21 RNA; PCNA; TGF 1

Indexed keywords

CYCLINE; DNA; PROTEIN P21; PROTEIN P53; RNA; TRANSFORMING GROWTH FACTOR BETA1;

ADVANCED CANCER; ARTICLE; CANCER STAGING; CANCER SURVIVAL; DNA SYNTHESIS INHIBITION; EARLY CANCER; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LABELING INDEX; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROGNOSIS; STOMACH CARCINOMA;

HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PROTO-ONCOGENE PROTEINS P21(RAS); STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0042473270     PISSN: 00235679     EISSN: 18812090     Source Type: Journal    
DOI: 10.2739/kurumemedj.50.1     Document Type: Article

References (24)

1. El-Deiry W., Harper J.W., O'Connor P.M., Velculescu V.E., Canman C.E. et al. WAF1/CIP1 is induced in p53-mediated Gl arrest and apoptosis. Cancer Res 1994; 54:1169-1174.
2. Harper J.W., Adami G.R., Wei N., Keyomarsi K., and Elledge S.J. The p21 CdK-interacting protein Cipl is a potent inhibitor of Gl cyclin-dependent kinases. Cell 1993;75:805-816.
3. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R. et al. ρ21 is a universal inhibitor of cyclin kinases. Nature 1993; 366:701-704.
4. Noda A., Ning Y., Venable S.F., Pereira-Smith O.M., and Smith J.R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994;211:90-98.
5. Waga S., Hannon G.J., Beach D., and Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994; 369:574-578.
6. Dulic V., Kaufmann W.K., Wilson S.J., Tlsty T.D., Lees E. et al. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced Gl arrest. Cell 1994; 76:1013-1023.
7. Akagi M., Yasui W., Akama Y., Yokozaki H., Tahara H. et al. Inhibition of cell growth by transforming growth factor beta 1 is associated with p53-independent induction of p21 in gastric carcinoma cells. Jpn J Cancer Res 1996; 87:377-384.
8. Japanese Gastric Cancer Society. The general rules for gastric cancer study in surgery and pathology, 13th Edn, Kanehara, Tokyo, pp 4-13, 1999. (in Japanese)
9. Nevins J.R. E2F: A link between the Rb tumor suppressor protein and viral oncoprotein. Science 1992; 258:424-429.
10. Lees J.A., Saito M., Vidal M., Valentine M., Look T. et al. The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol 1993; 13:7813-7825.
11. La Thangue N.B. DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem Sci 1994; 19:108-114.
12. Roberts A.B., and Sporn M.B. Peptide growth factor and their receptors. In: Handbook of Experimental Pharmacology, ed. Roberts AB, Sporn MB, Springer-Verlag, Heidelberg, Vol 1, pp 419-431, 1990.
13. Massague J. The transforming growth factor-β family. Ann Rev Cell Biol 1990; 6:597-641.
14. Lyons R.N., and Moses H.L. Transforming growth factors and the regulation of cell proliferation. Eur J Biochem 1990; 187:467-473.
15. Barnard J.A., Lyons R.M., and Moses H.L. The cell biology of transforming growth factor β. Biochim Biophys Acta 1990; 1032:79-87.
16. Ewen M.E., Sluss H.K., Whitehouse L.L., and Livingston D.M. TGF β inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 1993; 74:1009-1020.
17. Geng Y., and Weinberg R.A. Transforming growth factor β effects on expression of Gl cyclins and cyclin-dependent protein kinases. Proc Natl Acad Sci USA 1993; 90:10315-10319.
18. Koff A., Ohtsuki M., Polyak K., Roberts J.M., and Massague J. Negative regulation of Gl in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 1993; 260:536-539.
19. Peter M., and Herskowitz I. Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 1994; 79:181-184.
20. Peters G. Stifled by inhibitions. Nature 1994; 371:204-205.
21. Datto M.B., Li Y., Panus J.F., Howe D.J., Xiong Y. et al. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 1995; 92:5545-5549.
22. Elbendary A., Berchuck A., Davis P., Havrilesky L., Bast R.C. Jr et al. Transforming growth factor β1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ 1994; 5:1301-1307.
23. Li C.Y., Suardet L., and Little J.B. Potential role of WAFl/Cipl/p21 as a mediator of TGF-β cytoinhibitory effect. J Biol Chem 1995; 270:4971-4974.
24. Datto M.B., Yu Y., and Wang X.-F. Functional analysis of the transforming growth factor β responsive elements in the WAFl/Cipl/p21 promotor. J Biol Chem 1995; 270:28623-28628.